Salt Substitutes Significantly Lower High Blood Pressure Risk, Study Finds

Translate to Spanish or other 102 languages!

Using salt substitutes to reduce regular salt intake may help lower high blood pressure, research suggests. Image for illustration purposes
Using salt substitutes to reduce regular salt intake may help lower high blood pressure, research suggests. Image for illustration purposes
- Advertisement -
  • Excess salt consumption is a known risk factor for developing high blood pressure.
  • New research shows swapping regular table salt for a salt substitute could helpregulate blood pressure in older adults.
  • Salt substitutes help minimize sodium intake while increasing potassium intake, both of which are associated with healthy blood pressure levels.

Overconsumption of salt is a global driver of cardiovascular disease and high blood pressure.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/salt-substitutes-significantly-lower-high-blood-pressure-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-13&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

The Connection Between Diet and Breast Cancer Risk

October is Breast Cancer Awareness Month, and many people may be wondering how to lower their risk.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Simple Steps to Soothe Arthritis Pain

Mega Doctor News CLEVELAND CLINIC - Osteoarthritis is the most common form of...
- Advertisement -